bf/NASDAQ:KTTA_icon.jpeg

NASDAQ:KTTA

Pasithea Therapeutics Corp.

  • Stock

USD

Last Close

4.56

26/07 20:00

Market Cap

5.45M

Beta: -

Volume Today

2.75K

Avg: 58.36K

PE Ratio

−0.56

PFCF: −0.43

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '20
Dec '21
Dec '22
Dec '23
revenue
15.06K
-
486.56K
3,130.37%
cost of revenue
17.27K
-
113.19K
555.25%
648.45K
472.86%
gross profit
-2.21K
-
373.36K
16,971.40%
-648.45K
273.68%
selling and marketing expenses
2.60M
-
-7.87B
302,761.73%
general and administrative expenses
9.92M
-
7.88B
79,292.97%
selling general and administrative expenses
40.98K
-
4.51M
10,892.58%
12.52M
178.00%
7.23M
42.27%
research and development expenses
2.67M
-
8.10M
203.92%
other expenses
44.72K
-
cost and expenses
40.98K
-
4.52M
10,934.73%
15.30M
238.37%
15.98M
4.42%
operating expenses
40.98K
-
4.51M
10,892.58%
15.19M
237.16%
15.33M
0.93%
interest expense
508
-
102
79.92%
ebitda
-40.98K
-
-4.51M
10,895.69%
-14.74M
227.10%
-15.33M
4.01%
operating income
-40.98K
-
-4.51M
10,899.06%
-14.82M
228.71%
-15.98M
7.85%
depreciation and amortization
61.48K
-
1.38K
97.76%
77.10K
5,490.79%
648.45K
741.09%
total other income expenses net
-4
-
2.33M
58,347,400%
879.87K
62.30%
471.61K
46.40%
income before tax
-40.98K
-
-2.17M
5,203.34%
-13.94M
541.19%
-15.51M
11.27%
income tax expense
-61.48K
-
508
100.83%
-879.97K
173,322.64%
453.91M
51,682.38%
net income
-40.98K
-
-2.17M
5,204.58%
-13.06M
500.57%
-15.96M
22.25%
weighted average shs out
688.92K
-
1.15M
66.99%
1.26M
9.73%
1.23M
2.83%
weighted average shs out dil
688.92K
-
1.15M
66.99%
1.26M
9.73%
1.23M
2.83%
eps
-0.06
-
-1.89
3,076.47%
-10.34
447.09%
-13.01
25.82%
epsdiluted
-0.06
-
-1.89
3,076.47%
-10.34
447.09%
-13.01
25.82%

All numbers in USD (except ratios and percentages)